chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Emergency Medical Technician was on-site during clinic performing medical observation of vaccine recipients.  Patient complained of feeling light-headed and general uneasiness.  BP taken by EMT was 170/90 and pulse 72.  Patient was aware and able to walk on her own.  Patient walked to her vehicle, assisted by EMT, but she returned to the building because she still wasn't feeling well.  EMT contacted emergency services for transport of the patient to Hospital ED.
late for their second dose / within the last year most likely due to COVID but didn't have any further details; This case was reported by a pharmacist via call center representative and described the occurrence of social problem in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, patient was might be two months late for their second dose of Shingrix within the last year most likely due to COVID, which led to social problem. The reporter stated that, did not have any further details. The reporter did not consent to follow up.
half of his tongue was swollen; swollen; contact dermatitis wrist; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swollen), DERMATITIS CONTACT (contact dermatitis wrist) and SWOLLEN TONGUE (half of his tongue was swollen) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Contact dermatitis. Concomitant products included ATORVASTATIN and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced JOINT SWELLING (swollen) and DERMATITIS CONTACT (contact dermatitis wrist). On 20-Jan-2021, the patient experienced SWOLLEN TONGUE (half of his tongue was swollen). At the time of the report, JOINT SWELLING (swollen) and DERMATITIS CONTACT (contact dermatitis wrist) outcome was unknown and SWOLLEN TONGUE (half of his tongue was swollen) had worsened. Contact dermatitis on one of his wrists was swollen.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included Benadryl.
This spontaneous report as received from a pharmacy technician refers to a 1 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 15-FEB-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source.; Sender's Comments: US-009507513-1802USA001558:
Approx 5-10 min after vaccine administration pt complained of loss of vision. Pupils were extremely dilated and skin was pale and clammy to touch. Vision returned in approx. 5 minutes. Once vision returned pt felt nauseous and subsequently vomited. After vomiting her pupils dilated and skin went pale and clammy again and pt stated again she could not see. This again lasted for approx. 5 minutes. EMS was called when the second episode of loss of vision started. EMS stated BP was low and pt was transported to the local hospital via ambulance.
Receiving 2nd dose 14 days after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receiving 2nd dose 14 days after the 1st dose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026d21a and 006d21a) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receiving 2nd dose 14 days after the 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receiving 2nd dose 14 days after the 1st dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication information was not provided. Concomitant medication information was not provided.
Began with muscles in legs aching, then a headache, body aches, feeling of being sick, chills.  Started feeling better two days after shot, but still weak.
Extreme fatigue, chills, aches, headache, nausea, every bone hurt, suicidal ideations
4 inch x 5 inch erythematous area on left thigh erythema for 3 days. No treatment. Pt to begin oral diphenhydramine and topical hydrocortisone 1%.
Pt had second Moderna vaccine in 02/2021. Pt tested positive for Covid 19 on 06/03/2021.
This non-serious spontaneous case, initially received from other health professional (nurse) on 19-Oct-2018, concerns a 41-year-old, adult male patient. The patient had no relevant medical history. The patient was not taking any concomitant medication at the time of vaccination. On 09-Oct-2018, the patient was administered FLUCELVAX QIVc [dose: 1.5 ml instead of 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 252235, expiry date: 30-Jun-2019]. At the time of this report, no adverse events were reported. This case was linked to original case 201804657 due to same reporter. Significant case amendment (19-Oct-2018): The description to be coded for the verbatim 'Received 1.5 ml dose instead of 0.5 ml' was changed from 'Extra dose administered' to 'Overdose'. The causality rationale was changed from 'The company assessed the causality of the event as not related to the suspect vaccine, considering the event as incidental in nature' to 'The company assessed the causality of the event as not related to the suspect vaccine, considering the event as accidental nature (medication error)'. The narrative and case comment was amended accordingly.
Mom came in 1 mth later with patient having rash on left leg. The rash was light pink to red and macular papular in nature, no itching. MD assessed the patient and determined that it looked like a rash from MMR not Varicella.
It felt tike the flu I had a low fever over on hundred a scratchy throat cough sneezing runny nose mucous sleepy tired lethargic, I am still waiting for the Doctor to call me back for an appointment I did not get any ovid-19medication but treated myself with OTC medications like ibuprofen.
pt recv vax;each time pt recv DT,devel fever 15 days/ vax;fever lasts five days; T range 101-103R;tx w/ apap;
24 hours post fever 101.0, chills, joint pain , muscle aches, and injection site pain/swelling
1 dose given to a patient 6 hours and 15 minutes after the first puncture; A spontaneous report was received from a pharmacist concerning a patient, age and gender unknown, who received Moderna's COVID-19 vaccine (mRNA-1273) resulting in the event, dose given to a patient 6 hours and 15 minutes after the first puncture.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 14 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number not provided) for prophylaxis of COVID-19 infection.  On 14 Feb 2021, a dose of Moderna's vaccine was administered to the patient 6 hours and 15 minutes after the first puncture of vial. No adverse event was reported by the patient after being given the vaccine. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the event, dose given to a patient 6 hours and 15 minutes after the first puncture, was considered resolved on 14 Feb 2021.; Reporter's Comments: This case concerns a patient of unknown gender and age who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Expired product administered without any associated adverse events.
FLUZONE (influenza) vaccine was administered on 11/22/2016 at 2:29 pm. At approx midnight, ten hours later, she woke with pruritus and rash to her neck, chest and shoulder. She took oral BENADRYL with some improvement, but rash and pruritus remain. For worsening or lack of improvement will go to ER.
My son was administered the Hep B vaccination by pharmaceutical company GlaxoSmithKline (lot no. 9Z924) on Tuesday 4/25/2017 and suffered 2 seizures on 4/27/2017. He was about 2.5 months at the time (born 2/17/17). I was advised by his Dr at the time to have him checked by the hospital and we were admitted to hospital on 4/29/2017. After extensive EEG testing, all results showed that he was healthy. He was given a second dose of Hep B vaccination on 08/02/17 by pharmaceutical company GlaxoSmithKlein (lot no. PN595) and suffered a seizure 2 days later. I was advised by his pediatrician  to bring my son to another Dr who ordered an overnight sleep study, which again showed healthy results. He was given the Varicella vaccination on 12/04/2018. The pharmaceutical company used was Merck & Co lot no. R018144. He had his 4th seizure of his life on 12/17/18. After which a full blood work panel was done which came back healthy. Dr ordered another EEG done on 1/3/2019 which came back with healthy results. My son has no medical diagnosis and he does not have any history of febrile seizures. He has had fevers with no seizure and the seizures he has had did not follow a high fever. His seizures are isolated incidents which leads me to believe that his body reacted to an ingredient in the vaccination.
Information has been received from a physician concerning a 19 year old female who on 20-MAR-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot no. 655994/1302F). On 22-MAR-2007, the patient developed a localized reaction at the injection which was cellulitis. Subsequently, the patient recovered. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report as received from a other health professional refers to a 1 year old female patient. The health care worker reported that her 1 year old granddaughter may have been vaccinated with a dose of HPV vaccine (unspecified) and could not rule out GARDASIL administration. The health care worker reported that in APR-2014, the patient was seen at physician's office and it was documented on the patient's immunization record that the patient received one dose of HPV vaccine (unspecified) and that the physician's office was unsure if the patient received the dose. No adverse effects reported. Additional information has been requested.
Patient stated her arm was very sore, tender and has a knot around the injection site.  She developed a headache and was extremely tired so she slept the next day.  She still has a sore arm  with a small knot around the injection site but is feeling better.
Breakthrough COVID-19 case: I didn't even know I had COVID-19. I was exposed. On 05/25/2022 - I tested myself and it came back negative. I had a slight scratchy throat but it didn't last. I went to Urgent care to get tested again and it came back positive. On 05/27/2022 - I had the Monoclonal Antibody Infusion. I have had very mild symptoms; slight runny nose, fatigue, sore throat and fatigue.  I'd like to suggest that there is common knowledge that we can  have the vaccine administered in the thigh which would help people that have comprised lymph nodes in both under arms.
fast breathing; fatigue; arm sorennes; left eyelid irritated; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sorennes), EYELID IRRITATION (left eyelid irritated), RESPIRATORY RATE INCREASED (fast breathing) and FATIGUE (fatigue) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm sorennes), EYELID IRRITATION (left eyelid irritated) and FATIGUE (fatigue). On 02-Feb-2021, the patient experienced RESPIRATORY RATE INCREASED (fast breathing). At the time of the report, PAIN IN EXTREMITY (arm sorennes), EYELID IRRITATION (left eyelid irritated), RESPIRATORY RATE INCREASED (fast breathing) and FATIGUE (fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concominant and treatment drugs were not provided. lab data and historical conditions were also not provided
Client reported itching beginning around the mouth then going to face and extremities.  Client was given Benadryl with symptom resolve.
Case number PHEH2013US026181, is an initial spontaneous report received from the consumer (patient's daughter) on 19 Dec 2013. This report refers to an 81-year-old male patient. His current conditions included chronic COPD and emphysema for which he used antibiotics and steroids. His concomitant medications were not reported. He was vaccinated with one dose of influenza (manufacturer and batch number: unknown) on 13 Sep 2013. He was vaccinated with another dose of influenza (unknown manufacturer, batch number: not reported) on 12 Dec 2013. Immediately after this second vaccination, he experienced severe aching, weakness, choking cough without mucus and felt very sick. He visited the emergency room on 14 Dec 2013 where he was admitted and released on 17 Dec 2013. Patient's daughter stated that nothing has changed since the hospital admission and her father was still feeling achy, sick and very weak since he received the second flu shot. The causality was not reported.
Blood clots formed in the portal veins to the liver blocking the blood supply to the liver causing necrosis. Symptoms included fevers, chills, weight loss, lethargy.  Ended up spending 7 days in the hospital with a liver drain inserted to drain off infection.  Pic line for antibiotics inserted along with oral antibiotics. Sent home to recover with drain, pic line and antibiotics.
Local reaction on both arms consisting of mild edema and erythema. Pt first noticed 40 hrs post shot administration. Progressively local symp increased within a few hours. No systemic symptoms. While in clinic he developed mild to moderate wheezing (48 hrs post). All symptoms responded well to Benadryl, Albuterol Neb, Prednisone, On D/C local reaction subsiding, wheezing clear next day. Local reactions continues to improve.
Injection site pain (not as severe as first dose). Starting approximately 18 hours post injection, extreme fatigue (slept for 24-30 hours off and on), body aches in lower back and both shoulder joints.  Blood sugar was previously well controlled but spiked for several days after injection (levels >300).
Broke out in itchy, raised rash 3/21 with symptoms of fever on that day. Seen by physician on 3/22/ diagnosis of "Varicella"
I?m 17 weeks pregnant. Around 10 pm i started having body aches and a low grade fever of 99.5. Took some Tylenol. I couldn?t sleep due to the body aches and chills and headache. I slept 1am-3am and took 3 hot showers trying to help with the body aches. I vomited around 3am and my fever was 100.  I continued to take Tylenol every 6 hours for 48 hours. My temp stayed at 100-100.5. My headache continued along with the body aches & nausea & vomiting until 1/30 at 10pm.
I developed rash on right side of my chest and back one day after receiving my first Moderna COVID 19.  I contacted a Physician's Assistant of my employer who administered vaccine by phone to describe my symptoms  and was told my symptoms resembled Shingles symptoms. I subsequently went to urgent care and was diagnosed with Shingles.  The Shingles rash provided some minor skin irritation but was not painful. The rash dissipated after four weeks. I subsequently received the Shingles vaccination in late July and early September of 2021.
Patients left arm was sore and uncomfortable, woke her up during sleep. When looked at it site purple and red from elbow to shoulder. Family MD determined a vessel was nicked during injection.
first dose March of 2020, 2nd dose 18 months after; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix vaccine (1st dose received in March 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient received the 2nd dose later than the recommended time frame, which led to lengthening of the  vaccine schedule. The patient inquired so he/she consider the the dose or get the 3rd dose.
J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 8/7/2022 ANEMIA    CHF, STAGE D
I got a patch of redness on my injection arm; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 17Aug2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included acne and known allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included minocycline (MANUFACTURER UNKNOWN) and azelaic acid (MANUFACTURER UNKNOWN); both for acne from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received azithromycin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 17Aug2021, the patient got a patch of redness on her injection arm that looks like an independent country. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event patch of redness on her injection arm that looks like an independent country was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a medical assistant concerning a healthy 14 month old white female with no allergies or medical history who on 13Apr05 was vaccinated in the right arm with an expired first dose of varicella virus vaccine live (lot 642052/0108P). Concomitant vaccination on the same day included first dose in the left arm of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 649514/0777P). There was no concomitant medication. Over the weekend of 16Apr05 and 17Apr05, the pt developed a rash, fever, and a swollen face. Diphenhydramine hydrochloride (Benadryl) was prescribed and the pt was to be seen by the physician on 18Apr05. At the time of the report, the pt had not recovered. A product quality complaint was not involved. Additional information was received from the medical assistant who indicated that on 18Apr05 the pt's mother called the office and reported that the child had a swollen face, rash all over her body. and a low grade fever. The pt was seen on 18Apr05 and diagnosed with probable hand-foot and mouth. It was unk if the pt recovered. No further information is expected.
Right deltoid red, swollen and warm to touch for 2 days.  Treatment: warm soaks/MOTRIN.
Pt was given PENTACEL first and then PREVNAR - as soon as the PREVNAR was administered, pt developed a red rash (? hives) on face and chest area. No increased WOB, no wheezing.
Bones and joints popping, snapping and clicking; Bones and joints popping, snapping and clicking; pain in joints and fingers; pain in joints and fingers; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration, administered in left shoulder on 25Apr2021 at the age of 59 years old as a single dose for COVID-19 immunisation. The patient's medical history included Cholecystectomy from 31Mar2021. The patient's concomitant medications were not reported. The patient had not visited emergency room or physician office due to the event. On an unspecified date the patient experienced Bones and joints popping, snapping and clicking, pain in joints and fingers. The reporter reported that the same time as the popping, snapping, and clicking. It happened kind of after use, and after doing physical activity. The pain had stayed the same. NDC was unknown, does not have vaccine card or any thing with this information on it. The patient reported the time vaccination was given in mid morning. The patient had received the first dose of Pfizer vaccine probably 13 days, for this way the patient had second shot in 2 days, now his concern was since patient had the shot, the first shot all joints keep popping, like just popping, and clicking. The patient concerned was if he felt that it was a side effects and if the patient had the second shot will this get worst, or like patient was trying to pause of what we get from the second shot, or not which is due in 2 days, every time the patient move, click every time move his neck, knees, fingers, elbows, and knees it just keep clicking. The patient did not receive any treatment for events. The outcome of the events was not recovered.  The caller was provided with phone number and hours of operation for COVID-19 vaccine inquiries, prior to warm transfer.  Follow-up on 03May2021, This is a follow up spontaneous report from a contactable consumer included Patient's information, age at vaccination, and concomitant medication information updated.  Follow-up attempts are completed. information about lot/batch number cannot be obtained. No further information is expected.
A non-serious spontaneous report of earache, fever, body aches and stomach ache has been received from a physician concerning a 26-month-old female, subsequent to H1N1, Intranasal. Neither relevant medical history nor concomitant medications have been reported for this patient. On 04-Nov-2009, the patient received H1N1, Intranasal for an unknown indication. On 04-Nov-2009, shortly after the vaccine administration, the patient experienced fever of 103 F and body ache. The patient no longer had fever as of 18-Nov-2009. A stomach and earache were present at the time of report. The outcome of the fever was recovered, body aches was unknown and of stomach and earache not recovered.